Loading…
Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis
1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant. 2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes.
Saved in:
| Published in: | Cancer 2016-06, Vol.122 (19), p.3005-3014 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 3014 |
| container_issue | 19 |
| container_start_page | 3005 |
| container_title | Cancer |
| container_volume | 122 |
| creator | Deol, Abhinav Sengsayadeth, Salyka Ahn, Kwang Woo Wang, Hai-Lin Aljurf, Mahmoud Antin, Joseph Harry Battiwalla, Minoo Bornhauser, Martin Cahn, Jean-Yves Camitta, Bruce Chen, Yi-Bin Cutler, Corey S. Gale, Robert Peter Ganguly, Siddhartha Hamadani, Mehdi Inamoto, Yoshihiro Jagasia, Madan Kamble, Rammurti Koreth, John Lazarus, Hillard M. Liesveld, Jane Litzow, Mark R. Marks, David I. Nishihori, Taiga Olsson, Richard F. Reshef, Ran Rowe, Jacob M. Saad, Ayman A. Sabloff, Mitchell Schouten, Harry C. Shea, Thomas C. Soiffer, Robert J. Uy, Geoffrey L. Waller, Edmond K. Wiernik, Peter H. Wirk, Baldeep Woolfrey, Ann E. Bunjes, Donald Devine, Steven de Lima, Marcos Sandmaier, Brenda M. Weisdorf, Dan Khoury, Hanna Jean Saber, Wael |
| description | 1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant.
2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes. |
| doi_str_mv | 10.1002/cncr.30140 |
| format | article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5030151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5030151</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_50301513</originalsourceid><addsrcrecordid>eNqlj81KxDAUhYMoTv3Z-AT3BTomTUN1o9Q6wwxMN9qFu3KNqUbSJCRpYd7eLty4dnXOx4EPDiE3jK4ZpcWttDKsOWUlPSEZo_dVvvTilGSU0rtclPxtRS5i_F6wKgQ_J6ui4kyUJcsIPjsVYXvoOLRTwqSdhf3oUSZ4ncKsZzSAQ1IBdmrE5LzTKmkJjTIGuoA2eoM2weAC1O3hEWpo9k9t9wK1RXOMOl6RswFNVNe_eUketpuu2eV-eh_Vh1Q2BTS9D3rEcOwd6v7vYvVX_-nmXtDlo2D834IfTJ1hrw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis</title><source>Wiley</source><source>EZB Electronic Journals Library</source><creator>Deol, Abhinav ; Sengsayadeth, Salyka ; Ahn, Kwang Woo ; Wang, Hai-Lin ; Aljurf, Mahmoud ; Antin, Joseph Harry ; Battiwalla, Minoo ; Bornhauser, Martin ; Cahn, Jean-Yves ; Camitta, Bruce ; Chen, Yi-Bin ; Cutler, Corey S. ; Gale, Robert Peter ; Ganguly, Siddhartha ; Hamadani, Mehdi ; Inamoto, Yoshihiro ; Jagasia, Madan ; Kamble, Rammurti ; Koreth, John ; Lazarus, Hillard M. ; Liesveld, Jane ; Litzow, Mark R. ; Marks, David I. ; Nishihori, Taiga ; Olsson, Richard F. ; Reshef, Ran ; Rowe, Jacob M. ; Saad, Ayman A. ; Sabloff, Mitchell ; Schouten, Harry C. ; Shea, Thomas C. ; Soiffer, Robert J. ; Uy, Geoffrey L. ; Waller, Edmond K. ; Wiernik, Peter H. ; Wirk, Baldeep ; Woolfrey, Ann E. ; Bunjes, Donald ; Devine, Steven ; de Lima, Marcos ; Sandmaier, Brenda M. ; Weisdorf, Dan ; Khoury, Hanna Jean ; Saber, Wael</creator><creatorcontrib>Deol, Abhinav ; Sengsayadeth, Salyka ; Ahn, Kwang Woo ; Wang, Hai-Lin ; Aljurf, Mahmoud ; Antin, Joseph Harry ; Battiwalla, Minoo ; Bornhauser, Martin ; Cahn, Jean-Yves ; Camitta, Bruce ; Chen, Yi-Bin ; Cutler, Corey S. ; Gale, Robert Peter ; Ganguly, Siddhartha ; Hamadani, Mehdi ; Inamoto, Yoshihiro ; Jagasia, Madan ; Kamble, Rammurti ; Koreth, John ; Lazarus, Hillard M. ; Liesveld, Jane ; Litzow, Mark R. ; Marks, David I. ; Nishihori, Taiga ; Olsson, Richard F. ; Reshef, Ran ; Rowe, Jacob M. ; Saad, Ayman A. ; Sabloff, Mitchell ; Schouten, Harry C. ; Shea, Thomas C. ; Soiffer, Robert J. ; Uy, Geoffrey L. ; Waller, Edmond K. ; Wiernik, Peter H. ; Wirk, Baldeep ; Woolfrey, Ann E. ; Bunjes, Donald ; Devine, Steven ; de Lima, Marcos ; Sandmaier, Brenda M. ; Weisdorf, Dan ; Khoury, Hanna Jean ; Saber, Wael</creatorcontrib><description>1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant.
2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.30140</identifier><identifier>PMID: 27315441</identifier><language>eng</language><ispartof>Cancer, 2016-06, Vol.122 (19), p.3005-3014</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Deol, Abhinav</creatorcontrib><creatorcontrib>Sengsayadeth, Salyka</creatorcontrib><creatorcontrib>Ahn, Kwang Woo</creatorcontrib><creatorcontrib>Wang, Hai-Lin</creatorcontrib><creatorcontrib>Aljurf, Mahmoud</creatorcontrib><creatorcontrib>Antin, Joseph Harry</creatorcontrib><creatorcontrib>Battiwalla, Minoo</creatorcontrib><creatorcontrib>Bornhauser, Martin</creatorcontrib><creatorcontrib>Cahn, Jean-Yves</creatorcontrib><creatorcontrib>Camitta, Bruce</creatorcontrib><creatorcontrib>Chen, Yi-Bin</creatorcontrib><creatorcontrib>Cutler, Corey S.</creatorcontrib><creatorcontrib>Gale, Robert Peter</creatorcontrib><creatorcontrib>Ganguly, Siddhartha</creatorcontrib><creatorcontrib>Hamadani, Mehdi</creatorcontrib><creatorcontrib>Inamoto, Yoshihiro</creatorcontrib><creatorcontrib>Jagasia, Madan</creatorcontrib><creatorcontrib>Kamble, Rammurti</creatorcontrib><creatorcontrib>Koreth, John</creatorcontrib><creatorcontrib>Lazarus, Hillard M.</creatorcontrib><creatorcontrib>Liesveld, Jane</creatorcontrib><creatorcontrib>Litzow, Mark R.</creatorcontrib><creatorcontrib>Marks, David I.</creatorcontrib><creatorcontrib>Nishihori, Taiga</creatorcontrib><creatorcontrib>Olsson, Richard F.</creatorcontrib><creatorcontrib>Reshef, Ran</creatorcontrib><creatorcontrib>Rowe, Jacob M.</creatorcontrib><creatorcontrib>Saad, Ayman A.</creatorcontrib><creatorcontrib>Sabloff, Mitchell</creatorcontrib><creatorcontrib>Schouten, Harry C.</creatorcontrib><creatorcontrib>Shea, Thomas C.</creatorcontrib><creatorcontrib>Soiffer, Robert J.</creatorcontrib><creatorcontrib>Uy, Geoffrey L.</creatorcontrib><creatorcontrib>Waller, Edmond K.</creatorcontrib><creatorcontrib>Wiernik, Peter H.</creatorcontrib><creatorcontrib>Wirk, Baldeep</creatorcontrib><creatorcontrib>Woolfrey, Ann E.</creatorcontrib><creatorcontrib>Bunjes, Donald</creatorcontrib><creatorcontrib>Devine, Steven</creatorcontrib><creatorcontrib>de Lima, Marcos</creatorcontrib><creatorcontrib>Sandmaier, Brenda M.</creatorcontrib><creatorcontrib>Weisdorf, Dan</creatorcontrib><creatorcontrib>Khoury, Hanna Jean</creatorcontrib><creatorcontrib>Saber, Wael</creatorcontrib><title>Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis</title><title>Cancer</title><description>1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant.
2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes.</description><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqlj81KxDAUhYMoTv3Z-AT3BTomTUN1o9Q6wwxMN9qFu3KNqUbSJCRpYd7eLty4dnXOx4EPDiE3jK4ZpcWttDKsOWUlPSEZo_dVvvTilGSU0rtclPxtRS5i_F6wKgQ_J6ui4kyUJcsIPjsVYXvoOLRTwqSdhf3oUSZ4ncKsZzSAQ1IBdmrE5LzTKmkJjTIGuoA2eoM2weAC1O3hEWpo9k9t9wK1RXOMOl6RswFNVNe_eUketpuu2eV-eh_Vh1Q2BTS9D3rEcOwd6v7vYvVX_-nmXtDlo2D834IfTJ1hrw</recordid><startdate>20160617</startdate><enddate>20160617</enddate><creator>Deol, Abhinav</creator><creator>Sengsayadeth, Salyka</creator><creator>Ahn, Kwang Woo</creator><creator>Wang, Hai-Lin</creator><creator>Aljurf, Mahmoud</creator><creator>Antin, Joseph Harry</creator><creator>Battiwalla, Minoo</creator><creator>Bornhauser, Martin</creator><creator>Cahn, Jean-Yves</creator><creator>Camitta, Bruce</creator><creator>Chen, Yi-Bin</creator><creator>Cutler, Corey S.</creator><creator>Gale, Robert Peter</creator><creator>Ganguly, Siddhartha</creator><creator>Hamadani, Mehdi</creator><creator>Inamoto, Yoshihiro</creator><creator>Jagasia, Madan</creator><creator>Kamble, Rammurti</creator><creator>Koreth, John</creator><creator>Lazarus, Hillard M.</creator><creator>Liesveld, Jane</creator><creator>Litzow, Mark R.</creator><creator>Marks, David I.</creator><creator>Nishihori, Taiga</creator><creator>Olsson, Richard F.</creator><creator>Reshef, Ran</creator><creator>Rowe, Jacob M.</creator><creator>Saad, Ayman A.</creator><creator>Sabloff, Mitchell</creator><creator>Schouten, Harry C.</creator><creator>Shea, Thomas C.</creator><creator>Soiffer, Robert J.</creator><creator>Uy, Geoffrey L.</creator><creator>Waller, Edmond K.</creator><creator>Wiernik, Peter H.</creator><creator>Wirk, Baldeep</creator><creator>Woolfrey, Ann E.</creator><creator>Bunjes, Donald</creator><creator>Devine, Steven</creator><creator>de Lima, Marcos</creator><creator>Sandmaier, Brenda M.</creator><creator>Weisdorf, Dan</creator><creator>Khoury, Hanna Jean</creator><creator>Saber, Wael</creator><scope>5PM</scope></search><sort><creationdate>20160617</creationdate><title>Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis</title><author>Deol, Abhinav ; Sengsayadeth, Salyka ; Ahn, Kwang Woo ; Wang, Hai-Lin ; Aljurf, Mahmoud ; Antin, Joseph Harry ; Battiwalla, Minoo ; Bornhauser, Martin ; Cahn, Jean-Yves ; Camitta, Bruce ; Chen, Yi-Bin ; Cutler, Corey S. ; Gale, Robert Peter ; Ganguly, Siddhartha ; Hamadani, Mehdi ; Inamoto, Yoshihiro ; Jagasia, Madan ; Kamble, Rammurti ; Koreth, John ; Lazarus, Hillard M. ; Liesveld, Jane ; Litzow, Mark R. ; Marks, David I. ; Nishihori, Taiga ; Olsson, Richard F. ; Reshef, Ran ; Rowe, Jacob M. ; Saad, Ayman A. ; Sabloff, Mitchell ; Schouten, Harry C. ; Shea, Thomas C. ; Soiffer, Robert J. ; Uy, Geoffrey L. ; Waller, Edmond K. ; Wiernik, Peter H. ; Wirk, Baldeep ; Woolfrey, Ann E. ; Bunjes, Donald ; Devine, Steven ; de Lima, Marcos ; Sandmaier, Brenda M. ; Weisdorf, Dan ; Khoury, Hanna Jean ; Saber, Wael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_50301513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deol, Abhinav</creatorcontrib><creatorcontrib>Sengsayadeth, Salyka</creatorcontrib><creatorcontrib>Ahn, Kwang Woo</creatorcontrib><creatorcontrib>Wang, Hai-Lin</creatorcontrib><creatorcontrib>Aljurf, Mahmoud</creatorcontrib><creatorcontrib>Antin, Joseph Harry</creatorcontrib><creatorcontrib>Battiwalla, Minoo</creatorcontrib><creatorcontrib>Bornhauser, Martin</creatorcontrib><creatorcontrib>Cahn, Jean-Yves</creatorcontrib><creatorcontrib>Camitta, Bruce</creatorcontrib><creatorcontrib>Chen, Yi-Bin</creatorcontrib><creatorcontrib>Cutler, Corey S.</creatorcontrib><creatorcontrib>Gale, Robert Peter</creatorcontrib><creatorcontrib>Ganguly, Siddhartha</creatorcontrib><creatorcontrib>Hamadani, Mehdi</creatorcontrib><creatorcontrib>Inamoto, Yoshihiro</creatorcontrib><creatorcontrib>Jagasia, Madan</creatorcontrib><creatorcontrib>Kamble, Rammurti</creatorcontrib><creatorcontrib>Koreth, John</creatorcontrib><creatorcontrib>Lazarus, Hillard M.</creatorcontrib><creatorcontrib>Liesveld, Jane</creatorcontrib><creatorcontrib>Litzow, Mark R.</creatorcontrib><creatorcontrib>Marks, David I.</creatorcontrib><creatorcontrib>Nishihori, Taiga</creatorcontrib><creatorcontrib>Olsson, Richard F.</creatorcontrib><creatorcontrib>Reshef, Ran</creatorcontrib><creatorcontrib>Rowe, Jacob M.</creatorcontrib><creatorcontrib>Saad, Ayman A.</creatorcontrib><creatorcontrib>Sabloff, Mitchell</creatorcontrib><creatorcontrib>Schouten, Harry C.</creatorcontrib><creatorcontrib>Shea, Thomas C.</creatorcontrib><creatorcontrib>Soiffer, Robert J.</creatorcontrib><creatorcontrib>Uy, Geoffrey L.</creatorcontrib><creatorcontrib>Waller, Edmond K.</creatorcontrib><creatorcontrib>Wiernik, Peter H.</creatorcontrib><creatorcontrib>Wirk, Baldeep</creatorcontrib><creatorcontrib>Woolfrey, Ann E.</creatorcontrib><creatorcontrib>Bunjes, Donald</creatorcontrib><creatorcontrib>Devine, Steven</creatorcontrib><creatorcontrib>de Lima, Marcos</creatorcontrib><creatorcontrib>Sandmaier, Brenda M.</creatorcontrib><creatorcontrib>Weisdorf, Dan</creatorcontrib><creatorcontrib>Khoury, Hanna Jean</creatorcontrib><creatorcontrib>Saber, Wael</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deol, Abhinav</au><au>Sengsayadeth, Salyka</au><au>Ahn, Kwang Woo</au><au>Wang, Hai-Lin</au><au>Aljurf, Mahmoud</au><au>Antin, Joseph Harry</au><au>Battiwalla, Minoo</au><au>Bornhauser, Martin</au><au>Cahn, Jean-Yves</au><au>Camitta, Bruce</au><au>Chen, Yi-Bin</au><au>Cutler, Corey S.</au><au>Gale, Robert Peter</au><au>Ganguly, Siddhartha</au><au>Hamadani, Mehdi</au><au>Inamoto, Yoshihiro</au><au>Jagasia, Madan</au><au>Kamble, Rammurti</au><au>Koreth, John</au><au>Lazarus, Hillard M.</au><au>Liesveld, Jane</au><au>Litzow, Mark R.</au><au>Marks, David I.</au><au>Nishihori, Taiga</au><au>Olsson, Richard F.</au><au>Reshef, Ran</au><au>Rowe, Jacob M.</au><au>Saad, Ayman A.</au><au>Sabloff, Mitchell</au><au>Schouten, Harry C.</au><au>Shea, Thomas C.</au><au>Soiffer, Robert J.</au><au>Uy, Geoffrey L.</au><au>Waller, Edmond K.</au><au>Wiernik, Peter H.</au><au>Wirk, Baldeep</au><au>Woolfrey, Ann E.</au><au>Bunjes, Donald</au><au>Devine, Steven</au><au>de Lima, Marcos</au><au>Sandmaier, Brenda M.</au><au>Weisdorf, Dan</au><au>Khoury, Hanna Jean</au><au>Saber, Wael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis</atitle><jtitle>Cancer</jtitle><date>2016-06-17</date><risdate>2016</risdate><volume>122</volume><issue>19</issue><spage>3005</spage><epage>3014</epage><pages>3005-3014</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant.
2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes.</abstract><pmid>27315441</pmid><doi>10.1002/cncr.30140</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2016-06, Vol.122 (19), p.3005-3014 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5030151 |
| source | Wiley; EZB Electronic Journals Library |
| title | Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T00%3A29%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20FLT3%20Mutation%20Impact%20Survival%20after%20Hematopoietic%20Cell%20Transplant%20for%20AML?%20A%20CIBMTR%20Analysis&rft.jtitle=Cancer&rft.au=Deol,%20Abhinav&rft.date=2016-06-17&rft.volume=122&rft.issue=19&rft.spage=3005&rft.epage=3014&rft.pages=3005-3014&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.30140&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5030151%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_50301513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/27315441&rfr_iscdi=true |